The vascular principle in glaucoma appears to be a scientific rationale for the application of HBOT. On this sense, some scientific tests claimed an improvement while in the Visible field without important variations in intraocular pressure, in patients with glaucoma.OPDIVO + YERVOY, with chemotherapy, is usually a treatment choice for adults with�